期刊文献+

盐酸维拉帕米脉冲控释片的制备及体外释放度研究 被引量:6

Preparation and in vitro Release of Verapamil Hydrochloride Pulsatile Release Tablets
下载PDF
导出
摘要 制备了渗透泵控释的盐酸维拉帕米片芯,依次包时滞衣层和控释衣层制得脉冲控释片。考察了时滞衣层增重和控释衣膜处方及增重对药物释放时滞和释放速率的影响,同时比较了制品在不同释放介质中的释药行为。结果显示,时滞衣层增重与脉冲控释片的释放时滞呈正相关(r=0.9959),但对药物的释放速率影响较小;控释衣膜中的致孔剂种类和用量及控释衣层增重对体外释药均有不同程度的影响;释药孔的数量对药物释放影响较小,但释药孔的减少可能会导致衣膜膨胀变形。脉冲控释片的体外释放不受介质pH的影响。 The osmotic pump controlled-release verapamil hydrochloride tablets were coated with the inner coating layer (lag time) and outer coating layer (controlled-release) to prepare the pulsatile release tablets. The effects of coating thickness of the two layers and the formulation of the outer layer on lag time and release rate were investigated. The in vitro release behaviors of the products in different pH value media were also investigated. The results indicated that there was a linear correlation between the inner layer weight and lag time (r=0.9959). The thickness of the inner layer did not significantly affect drug release rate. The kinds and amount of pore-making agent and the thickness of the outer layer also affected drug release. Although the number of delivery orifice had rarely influence on drug release, less orifice would result in the expansion of tablets. Furthermore, the lag time and release rate were pH-independent.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2008年第6期423-427,共5页 Chinese Journal of Pharmaceuticals
关键词 盐酸维拉帕米 渗透泵 脉冲控释 时滞 非pH依赖性 verapamil hydrochloride osmotic pump pulsatile release lag time pH-independent
  • 相关文献

参考文献12

  • 1Smolensky MH. Chronobiology and chronotherapeutics. Applications to cardiovascular medicine[J]. Am JHypertens, 1996, 9 (4 Pt 3) : 11S-21S.
  • 2Traynor K, Newton DW, Hrushesky W J, et al. A pharmacist's primer on chronotherapeutics [J]. Am Pharm, 1992, NS32 (3) : 77-83.
  • 3Ozeki Y, Ando M, Watanabe Y, et al. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets [J]. J Controlled Release, 2004, 95 (1): 51-60.
  • 4Zhang Y, Zhang Z, Wu F. A novel pulsed-release system based on swelling and osmotic pumping mechanism [J]. J Controlled Release, 2003, 89 ( 1 ) : 47-55.
  • 5Li B, Zhu J, Zheng C, et al. A novel system for three-pulse drug release based on "tablets in capsule" device [J]. Int J Pharm, 2008, 352 (1-2): 159-164.
  • 6De Brabander C, Vervaet C, Remon JR Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion [J]. J Controlled Release, 2003, 89 (2) : 235-247.
  • 7Riis T, Bauer-Brandl A, Wagner T, et al. pH-Independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations [J]. Eur J Pharm Biopharm, 2007, 65 (1): 78-84.
  • 8Gupta SK, Atkinson L, Theeuwes F, et al. Pharmacokinetics of verapamil from an osmotic system with delayed onset [J]. EurJPharm Biopharm, 1996, 42 (1) : 74-81.
  • 9张彦,张志荣.硫酸特布他林脉冲控释片的制备与释放机理研究[J].药学学报,2003,38(11):854-858. 被引量:8
  • 10Pen KK, Wong CF. Application of similarity factor in development of controlled release diltiazem tablet [J]. Drug Dev indPharm, 2000, 26 (7) : 723-730.

二级参考文献9

  • 1[1]Theeuwes F. Triggered, pulsed and programmed drug delivery (A). Prescott LF, Nimmo WS. Novel Drug Delivery and Its Therapeutic Application [M]. New York: John Wiley & Sons Ltd, 1989.323-340.
  • 2[2]Krisztina TN, Bela N, Marta TK, et al. Acid-base properties of terbutaline in terms of protonation macro- and microconstants [J]. J Pharm Pharmacol, 1995,47(3):431-435.
  • 3[3]He SX, Song KY, Su ZY. Chrono-pharmacology and Chrono-therapy (时间药理学与时间治疗学) [M]. Tianjin: Tianjin Science and Technology Press, 1998.261-267.
  • 4[4]Matsuo M, Nakamura C, Arimori K, et al. Evaluation of hydroxyethylcellulose as a hydrophilic swellable material for delayed-release tablets [J]. Chem Pharm Bull, 1995,43(2):311-314.
  • 5[5]David QG, Adriana GQ, Daniel RT. Relationship between the swelling process and the release of a water-soluble drug from a compressed swellable-soluble matrix of poly (vinyl alcohol) [J]. Drug Dev Ind Pharm, 1999,25(2):169-174.
  • 6[6]Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) [J]. Adv Drug Del Rev, 2001,48(2):139-157.
  • 7[7]Lu B, Wang PY, Deng YJ, et al. New techniques and new dosage forms of drugs (药物新剂型与药物新技术)[M]. Beijing: People's Medical Publishing House, 1998.282-284.
  • 8[8]Michailova V, Titeva S, Kotsilkova R, et al. Water uptake and relaxation processes in mixed unlimited swelling hydrogels [J]. Int J Pharm, 2000,209(1):45-56.
  • 9[9]Theeuwe F. Elementary osmotic pump [J]. J Pharm Sci, 1975,64(11):1987-1991.

共引文献7

同被引文献93

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部